Plasma Noradrenaline as an Index of Sympathetic Activity

  • J. L. Reid
Part of the International Boehringer Mannheim Symposia book series (BOEHRINGER)


Plasma noradrenaline represents the small fraction of neurotransmitter noradrenaline released from peripheral sympathetic nerve endings which is not taken up into neuronal or extraneuronal tissue or metabolised by methylation or deamination and which overflows into the circulation. Plasma adrenaline in contrast is derived from the adrenal medulla and exerts its action as a blood borne hormone on metabolic, endocrine and vascular adrenergic receptors. In man, under most circumstance, noradrenaline levels in plasma are several fold higher than adrenaline unlike some animal species. In several studies, using different approaches, there is very little evidence, except during heavy physical exercise, that concentrations of noradrenaline achieved in plasma would significantly and directly influence arterial pressure or heart rate. When noradrenaline was infused intravenously to normal volunteers plasma concentrations had to increase by several fold to cause any change in systolic blood pressure (Fitz-Gerald et al., 1979). During Long-term intravenous infusions of noradrenaline to conscious dogs, an increase in circulating noradrenaline from 3.0 to 10.0 nmol/1 was not associated with significant changes in blood pressure (Casals-Stenzeletal., 1979).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Casals-Stenzel J, Tree M, Reid JL, Hamilton C, Brown JJ, Fraser R, Lever AF, Millar JA, Morton JJ, Robertson JIS (1979) Prolonged noradrenaline infusion in the conscious dog: Relation of plasma noradrenaline to arterial pressure. Circ Res (in press)Google Scholar
  2. Champlain J de, Cousineau D, Ameringen MR van, Marc-Aurele J, Yamaguehi N (1977) The role of the sympathetic nervous system in experimental and human hypertension. Postgrad Med Suppl 3 53: 15Google Scholar
  3. FitzGerald GA Hossman V, Hamilton CA, Reid JL, Davies DS, Dollery CT (1979) Interindividual variation in the kinetics of infused noradrenaline in man. Clin Pharmacol Ther (in press)Google Scholar
  4. Jones DH, Hamilton CA, Reid JL (1978) Plasma noradrenaline, age and blood pressure: a population study. Clin Sci Mol Med Suppl 4 55: 735Google Scholar
  5. Jones DH, Hamilton CA, Reid JL (1979a) The choice of control groups in the appraisal of sympathetic activity in essential hypertension. Clin Sci (in press)Google Scholar
  6. Jones DH, Allison DJ, Hamilton CA, Reid JL (1979 b) Selective venous sampling in the diagnosis and localization of phaeochromocytoma. Clin Endocrinol 10: 179CrossRefGoogle Scholar
  7. Lake CR, Zeyler MG, Coleman MD, Kopin IJ (1977) Age adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208PubMedCrossRefGoogle Scholar
  8. Louis WJ, Doyle AE, Anavekar S (1973) Plasma norepinephrine levels in essential hypertension. N Engl J Med 288: 599PubMedCrossRefGoogle Scholar
  9. Watson RDS, Hamilton CA, Reid JL, Littler WA (1979a) Plasma noradrenaline and systolic blood pressure during physical activity in hypertension. Hypertension (in press)Google Scholar
  10. Watson RDS, Page AJF, Littler WA, Jones DH, Reid JL (1979 b) Plasma noradrenaline at different vascular sites during rest and isometric and dynamic exercise. Clin Sci (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • J. L. Reid

There are no affiliations available

Personalised recommendations